Top Markets
Coin of the day
Carna Biosciences, Inc. Carna Biosciences, Inc.

Carna Biosciences, Inc.

4572
Κατάταξη σε μετοχές #25406
Carna Biosciences, Inc., established in Kobe, Japan in 2003, operates as a... Carna Biosciences, Inc., established in Kobe, Japan in 2003, operates as a clinical-stage biopharmaceutical company. Its core focus is on discovering and developing novel drug treatments for significant unmet medical needs, particularly within the Japanese market. In addition to its drug discovery efforts, Carna Biosciences offers an array of specialized research tools. These comprise diverse kinase proteins, their corresponding substrates, comprehensive kinase protein assay kits, stable cell lines, and biotinylated kinases, which are instrumental in investigating kinase-molecule interactions. The company also delivers a wide spectrum of scientific services. These services span from in-depth profiling and various cell-based kinase assays, including NanoBRET TE and ClariCELL intracellular assays, to protein detection and interaction analysis, live-cell kinase assays, crystallization, and weak affinity chromatography. Furthermore, they provide tyrosine kinase cell-based assay services and custom synthesis of ultra-pure proteins specifically for crystallography. Its therapeutic pipeline highlights several key investigational compounds. AS-0141, an orally administered small molecule designed to inhibit CDC7 kinase, is currently undergoing preclinical studies for cancer treatment. Another small molecule, AS-0871, is advancing through Phase 1 clinical trials for inflammatory and immune disorders. Moreover, AS-1763, an orally bioavailable, non-covalent inhibitor, is in preclinical assessment for chronic lymphocytic leukemia and other B-cell malignancies. Strategic collaborations have been established with leading pharmaceutical organizations, including Johnson & Johnson, Sierra Oncology, Sumitomo Dainippon Pharma, Gilead Sciences, and BioNova Pharmaceuticals.
Τιμή μετοχής
$2.62
Κεφαλαιοποίηση
$50.19M
Αλλαγή (1 ημέρα)
-1.47%
Αλλαγή (1 έτος)
77.21%
Χώρα
JP
Εμπόριο Carna Biosciences, Inc. (4572)

Κατηγορία

Ιστορικό τιμής μετοχής για την Carna Biosciences, Inc. (4572)
Υψηλότερη τιμή κλεισίματος: $2.33 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $9.84 στις 2008-03-01
Ιστορικό τιμής μετοχής της Carna Biosciences, Inc. από 2008 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -2.66%
2025 11.27%
2024 -56.72%
2023 0.20%
2022 -48.88%
2021 -27.88%
2020 -39.08%
2019 101.34%
2018 -2.61%
2017 -38.05%
2016 -28.59%
2015 261.37%
2014 -16.25%
2013 159.13%
2012 -15.00%
2011 -31.55%
2010 -18.51%
2009 -1.93%
2008 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$539.14 35.65%
US
$1.04K 56.21%
NL
$117.80 -18.86%
AU
$761.87 8.65%
CH
$130.43 397.46%
US